Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Aug 7, 2017 · 10-Q · 38 days after period end · 0001171843-17-004786
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Net Income | -$5.61M | -$7.91M | -$5.07M | -$2.56M |
| EPS Diluted | -$0.33 | -$0.48 | -$0.31 | -$18.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 7, 2017 · 38 d after period end
